Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of the Feasibility and Efficacy of Breast Conserving Surgery in Patients With MRI Detected Multi-Centric Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01100489
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:14.402769+00:00
Published At
2011-12-08T00:00:00+00:00
Record Updated At
2011-12-08
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ductal Breast Carcinoma in Situ", "Estrogen Receptor-negative Breast Cancer", "Estrogen Receptor-positive Breast Cancer", "HER2-negative Breast Cancer", "HER2-positive Breast Cancer", "Invasive Ductal Breast Carcinoma", "Invasive Lobular Breast Carcinoma", "Male Breast Cancer", "Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate", "Mucinous Ductal Breast Carcinoma", "Papillary Ductal Breast Carcinoma", "Progesterone Receptor-negative Breast Cancer", "Progesterone Receptor-positive Breast Cancer", "Stage I Breast Cancer", "Stage II Breast Cancer", "Tubular Ductal Breast Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2011-12-08"
protocolSection.identificationModule.nctId
"NCT01100489"
protocolSection.identificationModule.officialTitle
"A Phase II Study of the Feasibility and Efficacy of Breast Conserving Surgery in Patients With MRI Detected Multi-Centric Breast Cancer"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ductal Breast Carcinoma in Situ (protocolSection.conditionsModule.conditions)
  • Estrogen Receptor-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • Estrogen Receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • HER2-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • HER2-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • Invasive Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Invasive Lobular Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Male Breast Cancer (protocolSection.conditionsModule.conditions)
  • Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate (protocolSection.conditionsModule.conditions)
  • Mucinous Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Papillary Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Progesterone Receptor-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • Progesterone Receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage I Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Breast Cancer (protocolSection.conditionsModule.conditions)
  • Tubular Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.